Mass spectrometry based biomarker discovery, verification, and validation - Quality assurance and control of protein biomarker assays
نویسندگان
چکیده
منابع مشابه
Mass spectrometry-based quantitative analysis and biomarker discovery.
Mass spectrometry-based quantitative analysis and biomarker discovery using metabolomics approach represent one of the major platforms in clinical fields including for the prognosis or diagnosis, assessment of severity and response to therapy in a number of clinical disease states as well as therapeutic drug monitoring (TDM). This review first summarizes our mass spectrometry-based research str...
متن کاملBiomarker discovery and validation.
Currently available biomarkers, such as those used to diagnose myocardial infarction (e.g., cardiac troponins), were identified in the course of targeted physiologic studies. Similarly, basic investigation of diseases has largely been characterized by studies of isolated molecules in cellular systems. Advances in genomics technologies, however, are beginning to permit characterization of global...
متن کاملLabel-free mass spectrometry-based proteomics for biomarker discovery and validation.
For most diseases, better biomarkers are urgently needed to enable (early) detection, diagnosis, prognosis, stratification for therapy and response monitoring. Proteomics delineates gene products that carry out the majority of cellular functions, and thereby may not only yield insight into altered signaling pathways in disease, but also yield novel biomarkers. In recent years, great progress ha...
متن کاملNeuroimaging-based biomarker discovery and validation.
Although developing biological markers for chronic pain has been a major goal of the field for decades, such biomarkers have not yet made their way into clinical practice. However, given the potential uses of biomarkers in multiple aspects of prevention and treatment—suchaspain and risk factor assessment, diagnosis, prognosis, treatment selection, drug discovery, and more—efforts to discover ne...
متن کاملMass Spectrometry and Biomarker Development
The natural history of disease is usually a story of progression from an early stage in which homeostasis is only mildly perturbed and easily restored, through a series of increasingly involved stages characterized by a steady increase in the extent and impact of pathological change. Eventually the disease process becomes irreversible, and treatment is ameliorative at best. One of the major goa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular Oncology
سال: 2014
ISSN: 1574-7891
DOI: 10.1016/j.molonc.2014.03.006